Nasdaq Falls Over 100 Points, Marker Therapeutics Shares Spike Higher
U.S. stocks traded mostly lower toward the end of trading, following the release of jobs data
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday’s Mid-Day Session
Gainers
Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.
Dow Drops 150 Points, Crude Oil Rises Over 2%
U.S. stocks traded lower midway through trading, following the release of jobs data
Markets Open Lower; U.S. Economy Adds Higher-Than-Expected Jobs In July
U.S. stocks traded lower this morning, following the release of jobs data
Lyft, DoorDash, Expedia And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
Atlas Corp. (NYSE: ATCO) rose 21.4% to $14.06 in pre-market trading after the company said it received a non-binding proposal from Poseidon Acquisition Corp. to acquire all outstanding common shares of Atlas for $14.45 per share.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
12 Consumer Discretionary Stocks Moving In Tuesday’s After-Market Session
Gainers
Solo Brands (NYSE:DTC) stock rose 9.1% to $4.55 during Tuesday's after-market session. The company's market cap stands at $288.4 million.
Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.